Stock Events

Stock Events

Jasper Therapeutics (JSPR) Q2 2024 Earnings

14MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-1.61

-1.12

-0.64

-0.15

Details

Expected EPS

-1.225

Actual EPS

-1.03

Surprise EPS

0.2

Surprise Percent

+15.92%

Description

Jasper Therapeutics (JSPR) has reported earnings of -1.03 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.